{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:37:17Z","timestamp":1772138237345,"version":"3.50.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"48","license":[{"start":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:00:00Z","timestamp":1540252800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2013-23897-104604-23"],"award-info":[{"award-number":["2013-23897-104604-23"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["523-2014-2336"],"award-info":[{"award-number":["523-2014-2336"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Heart Lung Foundation","award":["20120321"],"award-info":[{"award-number":["20120321"]}]},{"name":"Swedish Heart Lung Foundation","award":["20150557"],"award-info":[{"award-number":["20150557"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,21]]},"DOI":"10.1093\/eurheartj\/ehy621","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T07:10:08Z","timestamp":1537254608000},"page":"4257-4265","source":"Crossref","is-referenced-by-count":50,"title":["Association between renin\u2013angiotensin system inhibitor use and mortality\/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study"],"prefix":"10.1093","volume":"39","author":[{"given":"Gianluigi","family":"Savarese","sequence":"first","affiliation":[{"name":"Department of Medicine, Cardiology Unit, Karolinska Institutet, Karolinska University Hospital S1:02, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Dahlstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Cardiology Link\u00f6ping University, Link\u00f6ping, Sweden"},{"name":"Department of Medical and Health Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Vasko","sequence":"additional","affiliation":[{"name":"Department of Medicine, V\u00e4xj\u00f6 Hospital, Strandv\u00e4gen 8, V\u00e4xj\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars H","family":"Lund","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardiology Unit, Karolinska Institutet, Karolinska University Hospital S1:02, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,10,22]]},"reference":[{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B1","first-page":"257","article-title":"Microvascular endothelial dysfunction in heart failure with preserved ejection fraction","volume":"102","author":"Lam","year":"2016","journal-title":"Heart"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B2","first-page":"1575","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B3","first-page":"767","article-title":"Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B4","first-page":"772","article-title":"Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B5","first-page":"1667","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B6","first-page":"293","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Investigators S","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B7","first-page":"1429","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","author":"Group","year":"1987","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B8","first-page":"478","article-title":"Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II","volume":"30","author":"Komajda","year":"2008","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B9","first-page":"2129","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B10","first-page":"717","article-title":"Heart failure in elderly patients: distinctive features and unresolved issues","volume":"15","author":"Lazzarini","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B11","first-page":"25","article-title":"Heart failure registry: a valuable tool for improving the management of patients with heart failure","volume":"12","author":"Jonsson","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B12","first-page":"188","article-title":"A comparison of two methods of estimating propensity scores after multiple imputation","volume":"25","author":"Mitra","year":"2016","journal-title":"Stat Methods Med Res"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B13","first-page":"2318","article-title":"Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study","volume":"36","author":"Edner","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B14","first-page":"1010","article-title":"Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF)","volume":"157","author":"Forman","year":"2009","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B15","first-page":"162","article-title":"Current use of guideline-based medical therapy in elderly patients admitted with acute heart failure with reduced ejection fraction and its impact on event-free survival","volume":"235","author":"Akita","year":"2017","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B16","first-page":"1326.","article-title":"Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry","volume":"20","author":"Savarese","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B17","first-page":"1093","article-title":"Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure","volume":"104","author":"Savarese","year":"2018","journal-title":"Heart"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B18","first-page":"1270","article-title":"Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry","volume":"19","author":"Lund","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B19","first-page":"724","article-title":"National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction","volume":"110","author":"Masoudi","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B20","first-page":"391","article-title":"Treatment of heart failure in the elderly: never say it's too late","volume":"30","author":"Metra","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B21","first-page":"737","article-title":"A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications","volume":"149","author":"Ahmed","year":"2005","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B22","first-page":"450.","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"key\n\t\t\t\t2018122103590550200_ehy621-B23","first-page":"6","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br J Clin Pharmacol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/39\/48\/4257\/27206114\/ehy621.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T04:09:01Z","timestamp":1545365341000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/39\/48\/4257\/5142410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,22]]},"references-count":23,"journal-issue":{"issue":"48","published-online":{"date-parts":[[2018,10,22]]},"published-print":{"date-parts":[[2018,12,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehy621","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734280254.793552372","asserted-by":"object"}]},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,21]]},"published":{"date-parts":[[2018,10,22]]}}}